Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B ...
Nvidia shares extended their record-setting rally after U.S. President Donald Trump said he plans to discuss the company’s Blackwell artificial intelligence processors with Chinese leader Xi Jinping, ...
The surge comes amid mounting investor enthusiasm surrounding Nvidia’s dominance in AI infrastructure and optimism about ...
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and ...
Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...
Nancy Pelosi, one of the most prolific traders on Capitol Hill, is once again drawing attention for a highly profitable ...
NVIDIA has crossed the $5 trillion market cap threshold, becoming the first company to reach that valuation. The Santa Clara, ...
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily ...
Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide.
In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...
Eli Lilly and Company said the partnership will result in the build of the most powerful supercomputer owned by a pharmaceutical company.
In the AI boom, NVIDIA has continuously banked off the demands of AI tech needs for stronger and more efficient hardware.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results